DIVIS LABORATORIES
Back to Income Statement
|
DIVIS LABORATORIES Last 5 Year Appropriations History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Appropriations | ₹13,977 Cr | ₹12,559 Cr | ₹11,812 Cr | ₹10,558 Cr | ₹7,779 Cr |
What is the latest Appropriations of DIVIS LABORATORIES ?
| Year | Appropriations |
|---|---|
| Mar2025 | ₹13,977 Cr |
| Mar2024 | ₹12,559 Cr |
| Mar2023 | ₹11,812 Cr |
| Mar2022 | ₹10,558 Cr |
| Mar2021 | ₹7,779 Cr |
How is Appropriations of DIVIS LABORATORIES Trending?
| Years | Appropriations | % Change | |
|---|---|---|---|
| Mar2025 | ₹13,977 Cr | 11.29 | |
| Mar2024 | ₹12,559 Cr | 6.32 | |
| Mar2023 | ₹11,812 Cr | 11.88 | |
| Mar2022 | ₹10,558 Cr | 35.73 | |
| Mar2021 | ₹7,779 Cr | - | |
Compare Appropriations of peers of DIVIS LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| DIVIS LABORATORIES | ₹175,677.4 Cr | 4% | 5.2% | 11.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹415,073.0 Cr | -0% | -3.2% | -5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹134,121.0 Cr | 2.4% | 4.5% | 18.3% | Stock Analytics | |
| CIPLA | ₹118,431.0 Cr | -3.5% | -1.5% | -2.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,944.0 Cr | -3.2% | -3.3% | -10.6% | Stock Analytics | |
| MANKIND PHARMA | ₹90,806.8 Cr | 0.3% | 2.4% | -22.7% | Stock Analytics | |
DIVIS LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| DIVIS LABORATORIES | 4% |
5.2% |
11.9% |
| SENSEX | -2.6% |
-1.3% |
7.2% |
You may also like the below Video Courses